ID   2E2A6
AC   CVCL_RA98
DR   Wikidata; Q54584454
RX   Patent=US9249216;
RX   PubMed=23185348;
CC   Group: Patented cell line.
CC   Biotechnology: Used in a bioassay to measure botulinum toxin serotype A (BoNT/A) activity. Together with neuroblastoma cell line SiMa (Cellosaurus=CVCL_1695).
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P60880; Human SNAP25 (with p.Arg198_Gly206del; SNAP25(197)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
RX   Patent=US9249216;
RA   Fernandez-Salas E., Wang J., Garay P.E., Wong L.S., Hodges D.D.,
RA   Aoki K.R.;
RT   "Immuno-based botulinum toxin serotype A activity assays.";
RL   Patent number US9249216, 02-Feb-2016.
//
RX   PubMed=23185348; DOI=10.1371/journal.pone.0049516;
RA   Fernandez-Salas E., Wang J., Molina Y., Nelson J.B., Jacky B.P.S.,
RA   Aoki K.R.;
RT   "Botulinum neurotoxin serotype A specific cell-based potency assay to
RT   replace the mouse bioassay.";
RL   PLoS ONE 7:E49516-E49516(2012).
//